Keywords: |
letter; t-lymphocytes; cancer immunotherapy; melanoma; neoplasm proteins; deamination; amino acid sequence; protein processing, post-translational; cancer vaccine; cell culture; vaccination; epitope; cytotoxic t lymphocyte; melanoma cell; cytolysis; dna sequence; monophenol monooxygenase; codon; cross reaction; epitopes, t-lymphocyte; transplantation, autologous; aspartic acid; immunotherapy, adoptive; asparagine; sequence analysis, dna; immunization; clinical trials, phase i; humans; human; priority journal
|